Search
Search Constraints
You searched for: Author/Creator Sarmento-Ribeiro, Ana BelaLimit your search
- Sarmento-Ribeiro, Ana Bela [remove] 9
- 616.994061 5
- Cancer -- Chemotherapy -- Periodicals 5
- Drug resistance in cancer cells -- Periodicals 5
- Cancer -- Periodicals 2
- 18F-DOPA 18F-34-dihydroxyphenylalanine -- 18F-FDG 2-deoxy-2-[fluorine-18] fluoro-d-glucose -- 2-DG 2-deoxy-d-glucose -- 2HG 2-hydroxyglutarate -- 5-FU 5-fluorouracil -- AAD antiangiogenic drugs -- ABC ATP-binding cassette transporter -- ADT androgen deprivation therapy -- AI artificial intelligence -- ARE antioxidant response elements -- ASC adipose-derived mesenchymal stem cell -- Asn asparagine -- ASNS asparagine synthetase, ASS1, argininosuccinate synthase 1 -- BCAT1 branched-chain amino acid transaminase 1 -- BDNF brain-derived neurotrophic factor -- BPTES bis-2-(5-phenylacetamido-1, 3, 4-thiadiazol-2-yl)ethyl sulfide -- BSO buthionine sulfoximine -- BTKi Bruton's tyrosine kinase inhibitor -- C1P Cer-1-phosphate -- CAA cancer-associated adipocytes -- CAF cancer-associated fibroblasts -- CAXII carbonic anhydrase XII -- Cer ceramide -- CEBP-β CAAT enhancer binding protein-β -- CLCF1 cardiotrophin-like cytokine factor 1 -- cPLA2 cytosolic phospholipase A2 -- CSC cancer stem cells -- CSK C-terminal SRC kinase -- DON 6-diazo-5-oxo-l-norleucine -- DRM detergent-resistant membrane -- ECM extracellular matrix -- EGF epidermal growth factor -- EMA European Medicines Agency -- EMT epithelial-to- mesenchymal transition -- ENO enolase -- ER estrogen receptor -- ET endocrine therapy -- EVs extracellular vesicles -- FA fatty acid -- FAO Fatty acid oxidation -- FASN fatty acid synthase -- FDA Food and Drug Administration -- FGF fibroblast growth factor -- FPP farnesyl pyrophosphate -- G6PD glucose-6-phosphate dehydrogenase -- GCLC glutamate-cysteine ligase catalytic subunit -- GCN2 general control non-depressible 2 -- GGPP geranylgeranyl pyrophosphate -- GLS glutaminase -- GLUTs glucose transporters GPAT1, glycerol 3-phosphate acyltransferase -- GPER G-protein-coupled estrogen receptor -- GSH reduced glutathione -- GSSG oxidized glutathione -- H2O2 hydrogen peroxide -- HIF-1α hypoxia-inducible factor 1α -- HIF hypoxia-inducible factor -- HKII hexokinase II -- HMGCR 3-β-hydroxy-3-β-methyl glutaryl coenzyme A reductase -- HMGCS1 3-β-hydroxy-3-β-methylglutaryl coenzyme A synthase 1 -- ICIs immune checkpoint inhibitors -- IDH isocitrate dehydrogenase -- IDO1 indoleamine 2, 3-dioxygenase -- IFN-γ interferon gamma -- LD lipid droplets -- LDH lactate dehydrogenase -- LDL low density lipoprotein -- LKB1 liver kinase B1 -- LPA lysophosphatidate -- LPAR LPA receptor -- LPCAT2 lysoPC acyltransferase 2 -- LXR liver X receptor -- LysoPL lysophospholipids -- MCT monocarboxylate transporter -- MDR multidrug resistance -- ME malic enzyme -- MPC mitochondrial pyruvate carrier -- MSI mass spectrometry imaging -- mtDNA mitochondrial DNA -- NADPH reduced nicotinamide adenine dinucleotide phosphate -- NHE Na+/H+exchanger -- NMR nuclear Magnetic Resonance -- NQO1 NAD(P)H quinone oxidoreductase -- O2− superoxide anion -- OH hydroxyl radical -- OXPHOS oxidative phosphorylation -- P-gp P-glycoprotein -- PAG1 phosphoprotein associated with glycosphingolipid-enriched microdomains -- PDH pyruvate dehydrogenase -- PDK pyruvate dehydrogenase kinase -- PET-CT positron emission tomography coupled to computed tomography -- PFK phosphofructokinase -- PGC-1α peroxisome proliferator-activated receptor gamma coactivator 1-alpha -- PGD phosphogluconate dehydrogenase -- pHe extracellular pH -- PHGDH phosphoglycerate dehydrogenase -- PKM2 pyruvate kinase M2 -- PL phospholipid -- PLIN4 perilipin 4 -- PPAR peroxisome proliferator activated receptor -- PPI proton pump inhibitors -- PPP pentose phosphate pathway -- PTMA prothymosin α -- ROS reactive oxygen species -- RTK tyrosine kinase receptors -- S1P Sph-1-phosphate -- SAT1 spermidine/spermine N1-acetyltransferase -- SCD-1 stearoyl-coenzyme A desaturase-1 -- SLC solute carrier transporters -- SMs sphingomyelins -- SOD superoxide dismutase -- Sph sphingosine -- SREBP1 sterol regulatory element-binding protein 1 -- STAT3 signal transducer and activator of transcription 3 -- TCA tricarboxylic acid -- TDO tryptophan 2, 3-dioxygenase -- TG triglyceride -- TIF tumor interstitial fluid -- TKI tyrosine kinase inhibitors -- TME tumor microenvironment -- TPP+ phenol triphenyl alkyl phosphonium -- TSG tumor suppressor gene -- V-H+-ATPase vacuolar H+-ATPase -- VEGF vascular endothelial growth factor -- YAP yes-associated protein -- α-KG α-ketoglutarate 1
- 616.0705 1
- 616.994 1
- 616.9940654 1
- 616.99419 1
- ABC ATP-binding cassette -- ABCB1 ATP-binding cassette subfamily B member 1 -- ABCB10 ATP-binding cassette subfamily B member 10 -- ABCC ATP-binding cassette subfamily C -- ABCC1 ATP-binding cassette subfamily C member 1 -- ABCC3 ATP-binding cassette subfamily C member 3 -- ABCD1 ATP-binding cassette subfamily D member 1 -- ABCG2 ATP-binding cassette subfamily G member 2 -- 5-AC 5-azacytidine -- ADHFE1 Alcohol dehydrogenase iron containing 1 -- ADME Absorption, distribution, metabolism and excretion -- ADP Adenosine diphosphate -- AML Acute myeloid leukemia -- AP-2γ Transcription factor activating protein-2γ -- APAF-1 Apoptotic peptidase activating factor 1 -- APC APC regulator of Wnt signalling pathway -- ATM Ataxia telangiectasia mutated serine/threonine kinase -- ATR ATR serine/threonine kinase -- AUC Area under the plasma concentration versus time curve -- BAD BCL2-associated agonist of cell death -- BARD1 BRCA1 associated RING domain 1 -- BAX BCL-2- associated X protein -- BCL-XL B-cell lymphoma-extra large -- BCL-2 B-cell lymphoma protein 2 -- BCRP Breast cancer related protein -- BCRP-1 ATP-binding cassette super-family G member 2 is a protein that in humans is encoded by the ABCG2 gene -- BER Base-excision repair -- BID BH3-interacting domain death agonist -- Bim A pro-apoptotic member of the BCL-2 protein family -- BMI1 Polycomb complex protein -- BIRC3 Baculoviral IAP repeat-containing protein 3 -- BRCA Breast cancer susceptibility protein -- BRCA1 Breast cancer type 1 susceptibility protein -- BRIP1 BRCA1 interacting protein C-terminal helicase 1 -- CALCA Calcitonin related polypeptide alpha -- CAFs Cancer-associated fibroblasts -- CBLN2 Cerebellin 2 precursor -- CCBE1 Collagen and calcium-binding EGF domain-containing protein 1 -- CCDC8 Coiled-coil domain containing 8 -- CCNG1 Cyclin- G1 -- CD44 Cluster of Differentiation 44 -- CDH1 Cadherin-1 -- CDH13 T-cadherin also known as cadherin 13 -- CDKN2A Cyclin-dependent kinase inhibitor 2A -- CDKN2B Cyclin-dependent kinase 4 inhibitor B -- CH3 Methyl group -- CHEK1 Checkpoint kinase 1 -- CHEK2 Checkpoint kinase 2 -- Chk2 Checkpoint kinases 2 -- CHODL Chondrolectin -- Cmax Maximal plasma concentration -- CML Chronic myeloid leukemia -- CRC Colorectal cancer -- CRT1 Copper transporter 1 -- CSCs Cancer stem cells -- CTCs Circulating tumor cells -- CYP Cytochrome P450 -- CYP2A6 Cytochrome P450 family 2 subfamily A member 6 -- CYP2C19 Cytochrome P450 family 2 subfamily C member 19 -- CYP2D6 Cytochrome P450 family 2 subfamily D member 6 -- DAPK Death-associated protein kinase -- DDIs Drug-drug interactions -- DDR DNA damage response -- DCC DCC netrin 1 receptor -- DFS Disease free survival -- DNMT DNA methyltransferase -- DNMTi DNA methyltransferase inhibitor -- DPPA4 Developmental pluripotency associated protein 4 -- DPPA5 Developmental pluripotency associated protein 5 -- DSB Double strand breaks -- ECM Extracellular matrix -- EGFR Epidermal growth factor receptor -- EMT Epithelial-mesenchymal transition -- ERβ Estrogen receptor β -- ERCC1 Excision repair 1 endonuclease non-catalytic subunit -- ERCC2 ERCC excision repair 2, TFIIH core complex helicase subunit -- ESR Estrogen receptor -- EVs Extracellular vesicles -- 5-Fluorouracil 5-FU -- FA Fanconi anemia -- FAK Focal adhesion kinase -- FAM175A Coiled-coil domain-containing protein 98 -- FANCD2 FA complementation group D2 -- FANCL FA complementation group L -- FAS Fas cell surface death receptor -- FBXO17 F-Box Protein 17 -- FCGR2A Fc fragment of IgG receptor IIa -- FCGR3A Fc fragment of IgG receptor IIIa -- FDA U.S. Food and Drug Administration -- FLIP FLICE-inhibitory protein -- GDF3 Growth differentiation factor 3 -- ɤ-GGT Gamma-glutamyltransferase -- GNAO1 G protein subunit alpha o1 -- GOLPH3 Golgi phosphoprotein 3 -- GRIK1 Glutamate receptor, ionotropic, kainate 1 -- GSH Glutathione -- GSTP1 Glutathione S-transferase P1 -- HAND2 Heart and neural crest derivatives expressed protein 2 -- HCC Hepatocellular carcinoma -- HDAC Histone deacetylase -- HDACi Histone deacetylase inhibitor -- HER-2 Human Epidermal Growth Factor Receptor 2 -- HIF1A Hypoxia-inducible factor 1-alpha -- HIPK2 Homeodomain-interacting protein kinase 2 -- HLA Human leukocyte antigen -- HMAs Hypomethylating agents -- HMGB1 High mobility group box 1 -- hMLH1 Human mutL homolog 1 -- hMSH2 Human MutS homolog 2 -- hMSH3 Human MutS homolog 3 -- hMSH6 Human MutS homolog 6 -- HOX Homeobox -- HOXA9 Homeobox A9 -- HOXA10 Homeobox A10 -- HOXA11 Homeobox A11 -- HR Homologous recombination -- IAPs Inhibitor of apoptosis proteins -- ILK Integrin-linked kinase -- IRF8 Interferon regulatory factor 8 -- IRI Irinotecan -- ITH Intra-tumor heterogeneity -- JNK2 C-Jun N-terminal kinases -- KIT KIT proto-oncogene, receptor tyrosine kinase -- LIN28-A Lin-28 homolog A -- lncRNAs Long non-coding RNAs -- LONRF2 LON peptidase N-terminal domain and ring finger 2 -- MAB21L1 Mab-21 like 1 -- MAPK Mitogen-activated protein kinase -- MATEs Multidrug and toxin extrusion proteins -- MCL-1 Myeloid cell leukemia 1 -- MDR Multidrug resistance -- MGMT Methylguanine-DNA methyltransferase -- miRNAs microRNA -- MMPs Matrix metalloproteinases -- MMP2 Matrix metalloproteinase 2 -- MM Multiple myeloma -- MMR Mismatch repair -- MRE11A Double-strand break repair protein MRE11A -- MRP Multidrug resistance-associated protein -- MRP1 Multidrug resistance-associated protein 1 -- MRP7 Multidrug resistance-associated protein 7 -- MSI Microsatellite instability -- mTOR Mammalian target of rapamycin -- mTORC2 mTOR Complex 2 -- MYCL1 L-myc-1 proto-oncogene -- NANOG Nanog homeobox -- NBN Nibrin -- NER Nucleotide excision repair -- NGS Next generation sequencing -- NHEJ Non-homologous end joining -- NSCLC Non-small cell lung cancer -- NER Nucleotide-excision repair -- NOVA1 NOVA alternative splicing regulator 1 -- OAT Organic anion transporter -- OCT Organic cation transporter -- OCT1 Organic cation transporter 1 -- OCT-3/4 octamer-binding transcription factor ¾ -- OPCML Opioid binding protein/cell adhesion molecule like -- OS Overall survival -- p16INK4A Tumor suppressor protein p16INK4a -- p53 Tumor protein p53 -- PALB2 Partner and localizer of BRCA2 -- PARP Poly (ADP-ribose) polymerase -- PARPi Poly (ADP-ribose) polymerase inhibitor -- PD Pharmacodynamics -- PDAC Pancreatic ductal adenocarcinoma -- PDCs Patient-derived cell cultures -- PDGF-D Platelet-derived growth factor-D -- PDXs Patient derived xenografts -- PFS Progression free survival -- P-gp P-glycoprotein -- PharmGKB Pharmacogenomics Knowledgebase -- PHOX2A Paired mesoderm homeobox protein 2A -- PI3K-I Phosphatidylinositol 3-kinase-I -- PIK3C2A Phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing alpha polypeptide -- PK Pharmacokinetics -- PKB Protein kinase B -- PMEA 9-(2-phosphonylmethoxynyl)adenine -- POU5F1 POU domain, class 5, transcription factor 1, also known as Oct-4 -- PPIs Proton pump inhibitors -- PPP2R2A Protein phosphatase 2 regulatory subunit B alpha -- PTEN Phosphatase and tensin homolog -- PTGS2 prostaglandin-endoperoxide synthase 2 -- RAD50 Double strand break repair protein -- RAD51B RAD51 paralog B -- RAD51C RAD51 paralog C -- RAD51D RAD51 paralog D -- RAD54L DNA repair and recombination protein RAD54-like -- RARβ2 Retinoic acid receptor beta 2 -- RASSF1A Ras association domain-containing protein 1 -- RCC Renal cell carcinoma -- ROS Reactive oxygen species -- RXRG Retinoid X receptor gamma -- SCLC small cell lung cancer -- SGI-110 Guadecitabine DNMT inhibitor -- SLC Solute carrier -- SLC22A1 Solute carrier family 22 member 1 -- SLC5A10 Solute carrier family 5 member 10 -- SNVs Single nucleotide variants -- SOCS1 Suppressor of cytokine signalling 1 -- SORCS1 Sortilin related vps10 domain containing receptor 1 -- SPIN3 Spindlin family member 3 -- SPRY4 Sprouty homolog 4 protein -- SSB Single strand break -- SSRIs Selective serotonin reuptake inhibitors -- ST8SIA4 CMP-N-acetylneuraminate-poly-alpha-2, 8-sialyltransferase -- TAMs Tumor-associated macrophages -- TILs Tumor-infiltrating lymphocytes -- TKIs Tyrosine kinase inhibitors -- TLS Translesion synthesis -- TP53 Tumor protein p53 -- TME Tumor microenvironment -- TNF Tumor necrosis factor -- TNF-R1 Tumor necrosis factor receptor superfamily member 1A -- TRAIL TNF‐related apoptosis‐inducing ligand -- TRAIL-R1/DR4 TRAIL receptor 1/death receptor 4 -- TRAIL-R2/DR5 TRAIL receptor 2/death receptor 5 -- TRAIL-R3/DcR1 TRAIL receptor 3/decoy receptor 1 -- TRAIL-R4/DcR2 TRAIL receptor 4/ decoy receptor 2 -- TrpC5 a transient receptor potential channel 5 -- TYMS Thymidylate synthase -- UCH-L1 Ubiquitin carboxyl terminal hydrolase-L1 -- VDR vitamin D receptor -- VEGF Vascular endothelial growth factor -- VHL von Hippel–Lindau tumor suppressor -- VLA-4 Very late antigen-4 -- WBP5 WW domain binding protein 5 -- WLS Wntless Wnt Ligand Secretion Mediator -- Wnt Wnt signalling pathway -- XAF1 XIAP associated factor 1 -- XIAP X-linked inhibitor of apoptosis protein -- XPA Xeroderma pigmentosum complementation group A -- XPF Xeroderma pigmentosum complementation group F -- XRCC1 X-ray repair cross complementing 1 -- ZEB1 Zinc finger e-box binding homeobox 1 -- ZNF608 Zinc finger protein 608 -- ZNF69 Zinc finger protein 69 1